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Cancer of the cervix (Ca Cx) is the commonest 
gynecological malignancy among women in 
Uganda contributing about 80% of all female 
malignancies. The incidence rate is 40:100 000. 
It is the leading cause of cancer related deaths in 
females in Uganda. Unfortunately 80% of the 
patients present late and this makes treatment 
outcomes unsatisfactory. Most patients can only 
be treated palliatively. It is therefore important 
that the disease be detected in early stages so as 
to improve outcome. 
 
Objectives of the guidelines 
 
Main Objective: To improve the quality of care 
and prognosis of cancer of the cervix in Uganda. 
Specific objectives: Enable early detection, 
harmonize treatment, improve referral of 
patients and to create a  referral document for 





Several risk facts have been implicated. These 
include early sexual intercourse, early 
pregnancy (below 18 years), multiple sexual 
partners and high parity. The risk is also higher 
in women whose husbands have multiple sexual 
partners. It has been suggested that male 
circumcision plays a protective role but this has 
not been fully proven. 
 
 
There is a strong association with Human 
Papilloma Virus (HPV) infection - Types 16   
and 18 which are sexually transmitted diseases. 
Herpes Simplex Virus (type II) infection has 
also been implicated. There is emerging 
evidence that suppression of the immune system  
 
promotes the development of the cancer, as is 
the case with HIV/AIDS and organ transplant 
patients. 
 
Ca Cx is commoner in women of low socio–
economic class but the low socio-economic 
class is not an independent risk factor.  A diet 
low in vitamins A, C, Beta carotene and Folic 
acid has also been implicated. Tobacco use has 
been identified as an independent risk factor. 
However the role of alcohol consumption has 




Prevention is interactive with that of sexually 
transmitted infections (STI) and is aimed at 
delayed sexual intercourse and use of condoms. 




Currently, there is no infrastructure for a nation-
wide screening programme in Uganda. 
However, the following are the established 
procedures, which should be routinely carried 
out. 
• Unaided visual inspection of the 
cervix  
• Visual inspection aided by acetic 
acid and Lugol’s iodine (may be 
done in  Health center IV) 
• Colposcopy, Pap smear 
(Papanicolaou smear)  
Clinical Presentation 
 
Early Clinical Features 
 
Most of the patients present in the 4th and 5th 
decades. The early symptoms of cervical cancer 
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include postcoital or contact bleeding, offensive 
vaginal discharge and inter-menstrual vaginal 
bleeding. The early signs are difficult to 
demonstrate. In the early stages one may see 
nothing suspicious on a speculum examination; 
this does not exclude presence of disease! 
However, a hyperemic cervix or even an ulcer 
on the cervix may be noted. 
 
Late Symptoms and Signs. 
 
These include abnormal vaginal bleeding such 
as contact, spontaneous intermenstrual and 
postmenopausal bleeding. This is usually 
associated with an offensive vaginal discharge, 
lower abdominal pain, deep dyspareunia and 
backache. Other features may arise as a result of 
complications and or metastases from the 
disease process such as those due to ureteric 
involvement /obstruction and uremia, anemia, 
swelling of the lower limbs, fistulae formation 
such as vesico-vaginal fistula (VVF) and recto-
vaginal fistulae (RVF), haematuria and urethral 
obstruction.  
 
With the development of metastases, other 
features such as cough, ascites and bone pains 
may be observed depending on the site of the 
secondaries, however theses are rare as patients 





A vaginal speculum examination is essential. 
This is followed by an examination under 




A Pap smear/Cytology  
 
It is useful especially in the diagnosis of the 
cervical intraepithelial neoplasia. This involves 
scraping cells from the cervix, fixing and 
staining them on a glass slide and having them 
evaluated. All reproductive health clinics in the 
country should do a Pap smear and transport the 
slide to a referral center for the pathologist to 
report on  
The following are included in a cytological 
report: 
 Degree of dysplasia 
 Nuclear atypia (ratio of nucleus / 
cytoplasm) 
 Number of cells that are normal and 
abnormal. 
 Inclusion bodies 
 Abnormal division leading to 
microinvasion. 




When acetic acid is applied on the cervix, 
abnormal areas appear greyish white (aceto-





1. EUA-Examination under anaesthesia. 
2. Radiological   
      i). Abdominal And Pelvic Ultrasound. 
The following are checked for: 
- Cervical mass. 
- Parametrial infiltration.  
- Local and para-aortic lymph nodes 
(LN). 
- Bladder infiltration (mucosa and 
wall). 
- Rectal invasion. 
- Ascites. 
- Kidneys for Hydronephrosis 
- Abdominal metastases –Liver and 
spleen. 
- Pleural effusion 
     ii). CXR: For secondaries or other  disease 
complications 
iii) Intravenous Urography (IVU) gives 
additional information regarding renal 
function and level of ureteric 
obstruction. 
 iv.) CT Scan. (Where available) to check 
for: 
- Lymph nodes (Para-aortic and 
regional) 
- Size and site of tumor mass. 
- Parametrial involvement. 
- Secondaries in the liver and spleen. 
V). Other Plain Radiographs: as 
indicated. 
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3. Laboratory  
The most common complications of 
cervical cancer are anemia, renal failure 
and hypercalcaemia. Laboratory 
abnormalities include: anemia, electrolyte 
imbalances, elevated blood urea and 
serum creatinine levels. Hypercalcaemia 
may occur in advanced disease with bone 
involvement. 
4. Cystoscopy: for bladder mucosal invasion. 
5. Proctoscopy: for rectal mucosal 
involvement. 
Other investigations are indicated by the 
patient’s condition and presentation. For 
example 
sentinel node biopsy,  bone scan and 
tumor markers like carcino-embryonic 
antigen (CEA) which is used to monitor 
response to therapy and follow up. 
Squamous carcinoma antigen (SCA) can 




Stage I. Strictly confined to cervix 
1A. Preclinical carcinoma of cervix 
diagnosed only by microscopy.   
       Invasion is limited to measured 
stromal invasion with maximum depth 
of 5.0mm and no wider than 7.0mm. 
1A1. Stromal invasion no greater than 
3.0mm and no wider than 7.0mm. 
1A2. Maximum depth of invasion of 
stroma greater than 3mm but less 
than 5mm (taken from the base of 
epithelium-either squamous surface 
or glandular- from which it 
originates). The horizontal invasion 
should not be more than 7mm. 
1B. Clinical lesions confined to the cervix 
or preclinical lesions greater than 
stage 1A2. 
1B1. Clinical lesions less than 4.0cm      
in size 
1B2. Clinical lesions greater than 4.0cm 
in size 
Stage II. Extension beyond cervix but not to 
pelvic wall or lower third of the vagina.  
 IIA.Without parametrial invasion 
 IIB. With parametrial invasion 
 
Stage III Extension to pelvic wall, 
involves lower third of vagina, or causes 
hydronephrosis or non-functioning kidney.  
IIIA. Involves lower third of vagina, no 
extension to pelvic wall 
          IIIB. Extension to pelvic wall or causes 
hydronephrosis or non-functioning 
kidney. 
Stage IV 
IVA. Extension beyond true pelvis or 
involvement of bladder or rectal mucosa.       
(Bullous edema does not permit a case to 
be assigned to stage IV) 




Midwives are trained to recognize the clinical 
features and then refer the patient to Health 
center IV, where a pap smear / Biopsy can be 
done. Staging and treatment are done at 
Regional referral hospitals. 
 
Treatment of Cervical Cancer 
 
Surgery or radiotherapy when used alone or in 
combination are curative in early cervical 
cancer. 
Factors, which influence the choice of 
treatment, include the age and general condition 
of the patient, the stage of the tumor and the 




Early Disease: Stage 1-11a 
 
Surgery plays an important role in the 
management of early disease. 
Cervical Intra-epithelial Neoplasia (CIN) 
• CO2 Laser. 
• Cryosurgery. 
• Cone Biopsy 
 
Stage IA1. Simple hysterectomy is treatment of 
choice. A cone biopsy is done with strict life 
long follow up in selected patients who have not 
completed their families. 
 
Stage IA2. A modified radical hysterectomy 
±pelvic Lymphadenectomy is the recommended 
treatment (where the medial parametrium and 
the vaginal cuff are excised.) Doing a lymph 
node dissection on frozen section first is 
recommended. 
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- If negative, a simple hysterectomy is done 
- If positive, then a Wertheims 
hysterectomy is done. 
Stage IB1 – IIA Surgery: 
For Wertheim’s Hysterectomy  
   
Treatment of Late Disease: Stage Iib And 
Beyond 
The main treatment is radiotherapy. Surgery has 
only a limited role in late disease. Palliative 
Hysterectomy is not recommended. 
 
2.   RADIOTHERAPY 
  
Radiation therapy has a very important and 
effective role in the management of cancer of 
the cervix. In specifying the total dose to the 
pelvic wall the contribution from the 
intracavitary treatment will depend on the exact 
geometry of the sources and the size of the 
pelvis. In designing these regimens an 
approximation is made that the pelvic side wall 
receives 20% of the point a dose when a uterine 
tube and vaginal ovoids are used and almost 
nothing when ovoids alone are used. The 
philosophy behind the regimens is that the dose 
to a point A, 2 cm lateral to the central uterine 
canal and 2cm superior to the external source 
should be equivalent to the conventional 
intracavitary dose of 75-80 grays (Gy). Low 
dose rate andhigh dose rate brachytherapy may 
be used. 
 
Postoperatively the tolerance of the pelvis (after 
a Wertheim’s hysterectomy) is reduced to about 
45 Gy. If there is residual disease in the nodes or 
excision margins then an attempt to deliver a 
total of 60 Gy should be made by either 
additional external beam radiotherapy (EBRT) 
or intracavitory treatment (ICT). 
 
Early Disease  
 
 Stage IA. 
 If surgery can’t be done, radiotherapy can be 
curative. 
If a patient is unsuitable for surgery, 
intracavitary therapy (ICT) alone is sufficient. 
68-70 Gy is delivered in 2 insertions with a gap 
of 10 days. 
 
Stage IB / IIA. 
In young women with bulky tumor and positive 
lymph nodes, the treatment is external beam 
therapy (EBRT) of 50 Gy in 25 fractions over 5 
weeks. This is followed by ICT of 20-30 Gy, 
single fraction to point A. For patients who are 
older or have positive lymph nodes 
demonstrated at CT, or are not fit for or refuse 
surgery, EBT and ICT are given as above. 
 
Late Disease (Stage IIB and Beyond) 
 
Stage IIB – IIIB 
Radical radiotherapy is the treatment of choice. 
This requires both EBT of 50Gy in 25 fractions, 




These patients receive EBT of either 30Gy in 10 
fractions over 2 weeks or 50Gy in 25 fractions 
in 5 weeks depending on the patient’s clinical 




Treatment of metastases should be 
individualised depending on the site. The pelvis 
should be treated as above depending on the 
patients’ condition. A single pelvic EBRT of 8-





These are patients with an A-P separation of 
more than 21 cm.  In these patients a dose of 
50.4 Gy in 28 fractions over 5.5 weeks is given 
(i.e.1.8 Gy per fraction daily). This is followed 
by ICT according to the stage of the disease. 
 
Cervical Cancer in Pregnancy 
The management depends on the extent of the 
disease at the time of diagnosis, stage of 
pregnancy and wishes of the patient. 
 
In the first trimester of pregnancy, stage I 
disease is treated by Wertheim’s hysterectomy. 
If the disease is of more advanced stage, radical 
radiotherapy is given. 
 
In the second trimester, for stage I disease, the 
pregnancy is terminated by hysterotomy 
followed by a Wertheim’s hysterectomy at the 
same sitting. For stage II or more advanced 
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disease, radical radiotherapy (EBRT & ICT) are 
given as above. 
 
In the third trimester with a viable fetus, a 
caesarian section is carried out at 34-36 weeks 
for stage I disease followed by Wertheim’s 
hysterectomy at the same sitting. For stage II or 
more advanced disease, radical radiotherapy is 




If the disease recurs locally after primary 
surgery, radical radiotherapy is advised with 
EBT of 50.4Gy in 28 fractions over 5.5 weeks 
followed by a single ICT insertion of 20-30Gy. 
The patient may experience a greater than usual 
toxicity because of the previous operation.  
If the disease recurs after primary radiotherapy, 
it is often too advanced for salvage surgery.  
 
Radical hysterectomy for recurrent or persistent 
cervical cancer following radiotherapy can offer 
an alternative procedure to exenteration in 
highly selected patients (with FIGO Stage IB-
IIA, no clinical parametrial involvement and 
with a tumor less than 4cm in diameter at the 
time of the recurrence.) 
 
Positive Pelvic Lymph Nodes (after imaging or 
surgery) 
A dose of 50.4gy in 28 fractions over 5-6 weeks 
is given to the whole pelvis. This is followed by 
ICT according to stage.  
 
Positive Para-Aortic Lymph Nodes (On 
Imaging) 
Radiotherapy is the treatment of choice. 
An extended spade shaped parallel opposed pair 
to cover extended pelvis and L1-L4 inclusive is 
given aiming at 45 Gy in 25 fractions over 5 
weeks, followed by an extra 5Gy in 3 fractions 
to the extended pelvis.  
 
Cancer of the Cervical Stump 
 
In the rare cases of cancer of the cervical stump, 
this is treated according to stage as above.  
 
3. CHEMOTHERAPY 
The tumor is quite chemoresistant. 
Chemoradiation: This is where chemotherapy 
is given during radiotherapy as it has a 
radiosensitiser effect. There is now increasing 
evidence of chemo-sensitivity of cervical 
tumours to Platinum based chemotherapy 
regimens when given as concurrent 
chemoradiation. Chemoradiation is now the 
treatment of choice for those patients who are fit 
enough for Platinum based treatment, and when 
they have sufficient resources. 
Chemotherapy is rarely used in the palliative 
setting, as the most active drug (Cisplatin) has 
significant toxicity, and the aim of symptom 
control without causing side effects is difficult 
to achieve. The dose given is 40 mg per m2 
weekly during EBRT.  
 
Patient Follow-Up  
 
The follow-up policy is 1month after treatment 
and 2-monthly for the first year, 3-monthly in 
the second year then 6monthly from years 3 to 
5. Thereafter yearly follow up. This is because 
most recurrences occur in the first 2 years after 
treatment. The likelihood of relapse after 5 years 
is small. A pap smear six monthly for two years 
is recommended 
 
4. Palliative Care 
A multidisciplinary team approach is very 
important in the care of these patients and 
should be patient and family centered. 




Pain is managed according to the WHO 3-step 
analgesic ladder.  
Somatic Pain. Non-steroidal anti-inflammatory 
drugs (NSAIDS), may be needed for bone pain, 
which is very common in carcinoma of the 
cervix. The NSAIDS may have to be combined 
with opioids, as this is usually severe pain.  
Neuropathic Pain. Cervical cancer may invade 
nerve tissues manifesting with Neuropathic 
pain. Amitriptyline, anticonvulsant such as 
phenytoin, or both may be beneficial in treating 
this complication. 
 
Vaginal Discharge  
 
It could be composed of blood, pus, tissue, 
urine, stool or a combination of the above. 
Clean strips of cloth or sanitary pads or bundles 
of cotton could be utilized and changed 
regularly to ensure that the patient is dry and 
comfortable. 
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To prevent skin excoriation, zinc paste or 
Vaseline may be applied to the surrounding 
areas. 
 
There is need to decrease on the amount of 
bacterial growth by gently packing the vagina 
with clean cloths soaked with water mixed with 
bicarbonate soda powder (about one teaspoon in 
500ml of warm water) or metronidazole I.V. 
solution. A metronidazole solution can also be 
made by dissolving 5-10 crushed 200mg- tablets 
[non coated] in 500ml of water. The vaginal 
pack is left in situ for a couple of hours per day 
for about 5 days. Tablets of metronidazole can 
as well be inserted vaginally and serve the same 
purpose. A patient can easily apply this than the 
vaginal packing. Vaginal douching can be used, 
once or twice a day. 
 
Vesico-Vaginal Fistula And/Or Recto-
Vaginal Fistula 
 
Plastic panties with cotton cloth or cotton wool 
pads are used and can be   comforting to the 
patient as she will remain dry. Covering the bed 
with a plastic sheet can help to protect the linens 




Simple bed rest may help. Vaginal packs can 
effectively control bleeding. Radiotherapy may 
also help in controlling the bleeding. 
 
Leg Swelling (Lymphoedema) 
 
Raising the leg or bandaging it or support 
stockings are used.  
Skin care: avoiding any skin injuries e.g. extra 
care should be taken when cutting the nails. 
Lymph is a very good culture medium for 
bacteria and so the patient is susceptible to 
serious infection. If lymphangitis sets in, broad 
spectrum antibiotics e.g. Erythromycin or 
Septrin are administered.  
Massage to the limb may help in stimulation of 
lymphatic flow and may reduce on the swelling.  
 
Social, Emotional And Spiritual Issues 
 
Family stress Sexuality problems. It is important 
to support and discuss salient issues with the 
patient, husband, children and close  family 
friends. 
Sexual problems. Discussing with the couple 
may make them understand what is happening 
and helps them decide what is better for them. 
Avail opportunities for open and honest 
discussions for the patient and partner including 
alternatives to sexual intercourse. 
Spiritual issues. Spiritual beliefs can be 
comforting when death is approaching. Patients 
have questions about what is to happen. She 
may need to make peace with God so that her 
soul is safe after death. A spiritual advisor will 
play a role but it is important to respect people’s 
spiritual beliefs. Patients may need someone to 
talk to or pray with like religious leaders or 




The Uganda cancer working group:  AM 
Gakwaya ,  AJ Robinson,  JB Kigula Mugambe,   
AK Luwaga, E Kiguli-Malwadde, I Luutu, P 
Baguma, H Nalwoga, J Orem, E Othieno,  
F Mirembe, C Nakabiito, S M Kalisoke, G 
Busingye, P Kiondo, T Mutyaba, E Nabunya,  
J Jombwe, M Galukande, J Fualal, H Ddungu. 
 
References for Further Reading 
 
1.  Wabinga ,  Ramanakumar,  Banura,  
Luwaga ,  Namboze,  Parkin.  
Survival  of  Cervical  cancer  
patients in Kampala,  Uganda: 
1995 – 1997.Br.J.Cancer.2003:  
July 7;89(1):  65-69.  
2.  Parkin DM Cancer in developing 
countr ies.  Cancer surveys (1994) 
1920 :  519.  
3.  Rogo KO, Omany J,  Onyango JN, 
et  al .   Carcinoma of the cervix in 
the African sett ing Int .  J .  
Gynaecol Obstet  1990; 33:249 – 
55.  
4.  Wabinga HR, Parkin DM, 
Wabwire Mangeni and Mugerwa 
JW (1993) .  Cancer  in Kampala,  
Uganda in 1989 – 1991, changes 
in incidence in the eras of AIDS. 
Int .  J .  Cancer  54:26 – 36.  
5.  Parkin DM, Wabinga H. 
Nambooze S and Wabwire 
Mangeni (1999),  AIDS related 
cancers in a low resourced country 
:  maturation of  the epidemic in 
Uganda.   AIDS 1999,  13:256 – 
257.  
Cancer of the Cervix: The Uganda Guidelines.    Kiguli-Malwadde, AM Gakwaya, AJ Robinson et al 
 
East and Central African journal of Surgery             Volume 10 Number 2 – December 2005. 
99
6.  Wabinga,  Parkin,  Wabwire, 
NamboozeTrends in cancer  
incidence in Kyadondo county , 
Uganda 1960 – 1997.  Br.  J of 
cancer 2000 82(9) 1585 -  1592. 
7.  Walter and Millers (1998) 
Textbook of  Radiotherapy, 
gynaecological  cancers.  409-413. 
8.  Blake P.  (1999) Diagnosis and 
Follow-up of gynaecological  
Cancers.  Quali ty Manual  by Royal 
Marsden NHS Trust .  1-7.  
9.   IAEA –TECDOC-1224: The Role 
of  Radiotherapy in the 
management of Cancer patients 
Infected by the Human 
Immunodeficiency Virus (HIV)  
32-36.  
10.  Forum of Nuclear Co-operation in 
Asia (FNCA): application of 
Radio-Isotopes and Radiation for 
Medical  Uses:  Radiat ion Therapy 
of Stage IIIB Cervical  Cancer  for  
Asians,  Sept  2001. 
11.  Benedet J  l ,  Hackar N F,  Ngan 
HVS:2003 Edited Staging 
classif ication and clinical         
practice guidelines of  
gynaecological  cancers by  Figo 
committee  on Gynaecological 
Oncology and IGCS Guidelines 
committee.   
12.  Tabar L, Dean P B.Teaching Atlas 
of mammography. Thieme,  
strut tgart  1983. 
13.  Dronkers  D,  Hendriks J  H, 
Holland R, Rosenbusch G. The 
practice of Mammography.  Thieme 
,Struttgart  1999.  
 
 
  
 
